Gerald Kevin Oluka

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda”.

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda

Frontiers in Immunology(2023)10.3389/fimmu.2023.1113194

N/A

0DataRank · unranked

40 citations

Patricia Namubiru, Laban Kato, Violet Ankunda, Ben Gombe, Matthew Cotten +6 more

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months

Frontiers in Immunology(2023)10.3389/fimmu.2023.1152522

N/A

0DataRank · unranked

20 citations

Violet Ankunda, Jackson Sembera, Laban Kato, Gerald Kevin Oluka, Claire Baine +14 more

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

Frontiers in Immunology(2023)10.3389/fimmu.2023.1183983

N/A

0DataRank · unranked

13 citations

Claire Baine, Susan Mugaba, Violet Ankunda, Betty Oliver Auma, Gerald Kevin Oluka +11 more

Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals

Frontiers in Immunology(2023)10.3389/fimmu.2023.1255676

N/A

0DataRank · unranked

9 citations

Claire Baine, Violet Ankunda, Joseph Ssebwana Katende, Gerald Kevin Oluka, Christine Hermilia Akoli +9 more

An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2

BIO-PROTOCOL(2023)10.21769/bioprotoc.4905

N/A

0DataRank · unranked

9 citations

Jackson Sembera, Gerald Kevin Oluka, Joseph Ssebwana Katende, Violet Ankunda, Jennifer Serwanga +1 more

The Distinct Absence of a Post-boost Spike-IgG Antibody Surge in Ugandan Recipients of the Pfizer-BioNTech Vaccine Has Implications for Vaccination Policies

Preprints.org(2023)10.20944/preprints202310.0379.v1

N/A

0DataRank · unranked

1 citations

Violet Ankunda, Joseph Ssebwana Katende, Jackson Sembera, Gerald Kevin Oluka, Claire Baine +5 more

Silent Symptoms, Active Immunity: Insights into Early-Stage Cytokine Expressions in Ugandan Mild and Asymptomatic COVID-19 subjects

Research Square(2023)10.21203/rs.3.rs-3558086/v1

N/A

0DataRank · unranked

0 citations

Violet Ankunda, Ivan Ssali, Gerald Kevin Oluka, Susan Mugaba, Joseph Ssebwana Katende +13 more

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies

Frontiers in Immunology(2024)10.3389/fimmu.2024.1325387

N/A

0DataRank · unranked

7 citations

Joseph Ssebwana Katende, Gerald Kevin Oluka, Jackson Sembera, Claire Baine, Geoffrey Odoch +6 more

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles

PLoS ONE(2024)10.1371/journal.pone.0303113

N/A

0DataRank · unranked

5 citations

Gerald Kevin Oluka, Claire Baine, Violet Ankunda, Jackson Sembera, Laban Kato +8 more

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort

Frontiers in Immunology(2024)10.3389/fimmu.2024.1384668

N/A

0DataRank · unranked

2 citations

Laban Kato, Gerald Kevin Oluka, Violet Ankunda, Jackson Sembera, Claire Baine +8 more

The Single-Dose Janssen Ad26.COV2.S COVID-19 Vaccine Elicited Robust and Persistent Anti-Spike IgG Antibody Responses in A 12-Month Ugandan Cohort

Preprints.org(2024)10.20944/preprints202401.0089.v1

N/A

0DataRank · unranked

1 citations

Laban Kato, Violet Ankunda, Isaac Kitabye, Angella Namuyanja, Solomon Opio +7 more

Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort

Vaccines(2025)10.3390/vaccines13020143

N/A

0DataRank · unranked

8 citations

Jackson Sembera, Joseph Ssebwana Katende, Violet Ankunda, Laban Kato, Ashwini Kurshan +8 more

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK–Uganda Comparison

Vaccines(2025)10.3390/vaccines13040336

N/A

0DataRank · unranked

2 citations

Jackson Sembera, Gerald Kevin Oluka, Joseph Ssebwana Katende, Juliana Bemanzi, Violet Ankunda +10 more

Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralisation in a Ugandan Cohort

Preprints.org(2025)10.20944/preprints202501.0312.v1

N/A

0DataRank · unranked

3 citations

Jackson Sembera, Joseph Ssebwana Katende, Violet Ankunda, Laban Kato, Ashwini Kurshan +8 more